Spetzler David Baxley's Form 4 filing
Caris Life Sciences, Inc. (CAI) · filed Sep 4, 2026
- Accession no.
- 0002071953-26-000007
- Filed
- Sep 4, 2026, 4:59 PM ET
- Trade date
- Sep 3-4, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $14.8M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Spetzler David BaxleyCIK 0002071953 | Officer (President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | Common Stock | MOption exerciseAcquired | +1,000,000 | $2.44 | +$2,440,000 | 1,530,083 | Direct | |
| Sep 3, 2026 | Common Stock | SSaleDisposed | −393,100 | $24.76 | −$9,733,313.24 | 1,136,983 | Direct | |
| Sep 3, 2026 | Common Stock | SSaleDisposed | −84,900 | $25.32 | −$2,149,676.49 | 1,052,083 | Direct | |
| Sep 4, 2026 | Common Stock | MOption exerciseAcquired | +250,000 | $2.44 | +$610,000 | 1,302,083 | Direct | |
| Sep 4, 2026 | Common Stock | SSaleDisposed | −119,212 | $24.76 | −$2,951,116.9 | 1,182,871 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | Common Stock | MOption exerciseDisposed | −1,000,000 | $0.00 | $0 | 250,000 | Direct | |
| Sep 4, 2026 | Common Stock | MOption exerciseDisposed | −250,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.